193 related articles for article (PubMed ID: 7870885)
41. The anxiolytic-like effect of rutin in rats involves GABAA receptors in the basolateral amygdala.
Hernandez-Leon A; González-Trujano ME; Fernández-Guasti A
Behav Pharmacol; 2017 Jun; 28(4):303-312. PubMed ID: 28145981
[TBL] [Abstract][Full Text] [Related]
42. Blockade of histamine H2 receptors of the periaqueductal gray and inferior colliculus induces fear-like behaviors.
Santos NR; Huston JP; Brandão ML
Pharmacol Biochem Behav; 2003 Apr; 75(1):25-33. PubMed ID: 12759110
[TBL] [Abstract][Full Text] [Related]
43. Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphé reveals differential GABAergic control in two animal tests of anxiety.
Gonzalez LE; Ouagazzal AM; File SE
Eur J Neurosci; 1998 Dec; 10(12):3673-80. PubMed ID: 9875346
[TBL] [Abstract][Full Text] [Related]
44. Effects of glycine or (+/-)-3-amino-1-hydroxy-2-pyrrolidone microinjections along the rostrocaudal axis of the dorsal periaqueductal gray matter on rats' performance in the elevated plus-maze task.
Teixeira KV; Carobrez AP
Behav Neurosci; 1999 Feb; 113(1):196-203. PubMed ID: 10197919
[TBL] [Abstract][Full Text] [Related]
45. Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats.
Kask A; Rägo L; Harro J
Regul Pept; 1998 Sep; 75-76():255-62. PubMed ID: 9802417
[TBL] [Abstract][Full Text] [Related]
46. The blockade of AMPA-kainate and NMDA receptors in the dorsal periaqueductal gray reduces the effects of diazepam withdrawal in rats.
Souza-Pinto LF; Castilho VM; Brandão ML; Nobre MJ
Pharmacol Biochem Behav; 2007; 87(2):250-7. PubMed ID: 17537493
[TBL] [Abstract][Full Text] [Related]
47. Flumazenil reverses the decrease in the hypnotic activity of pentobarbital by social isolation stress: are endogenous benzodiazepine receptor ligands involved?
Ojima K; Matsumoto K; Watanabe H
Brain Res; 1997 Jan; 745(1-2):127-33. PubMed ID: 9037401
[TBL] [Abstract][Full Text] [Related]
48. A comparative study of the effects of morphine in the dorsal periaqueductal gray and nucleus accumbens of rats submitted to the elevated plus-maze test.
Anseloni VC; Coimbra NC; Morato S; Brandão ML
Exp Brain Res; 1999 Nov; 129(2):260-8. PubMed ID: 10591900
[TBL] [Abstract][Full Text] [Related]
49. Dopamine D2 receptors regulate unconditioned fear in deep layers of the superior colliculus and dorsal periaqueductal gray.
Muthuraju S; Talbot T; Brandão ML
Behav Brain Res; 2016 Jan; 297():116-23. PubMed ID: 26455877
[TBL] [Abstract][Full Text] [Related]
50. The dorsal periaqueductal gray modulates the increased fear-like behavior exhibited by experienced rats in the elevated plus-maze.
Kincheski GC; Carobrez AP
Behav Brain Res; 2010 Jan; 206(1):120-6. PubMed ID: 19737580
[TBL] [Abstract][Full Text] [Related]
51. 5-HT2C receptor regulation of defensive responses in the rat dorsal periaqueductal gray.
Yamashita PS; de Bortoli VC; Zangrossi H
Neuropharmacology; 2011; 60(2-3):216-22. PubMed ID: 20850460
[TBL] [Abstract][Full Text] [Related]
52. The depressant effect of GYKI 52466 on spinal reflex transmission in rats is mediated via non-NMDA and benzodiazepine receptors.
Block F; Schwarz M
Eur J Pharmacol; 1994 Apr; 256(2):149-53. PubMed ID: 8050465
[TBL] [Abstract][Full Text] [Related]
53. Anxiogenic-like effect induced by TRPV1 receptor activation within the dorsal periaqueductal gray matter in mice.
Mascarenhas DC; Gomes KS; Nunes-de-Souza RL
Behav Brain Res; 2013 Aug; 250():308-15. PubMed ID: 23707246
[TBL] [Abstract][Full Text] [Related]
54. Effects of neurokinin-1 and 3-receptor antagonists on the defensive behavior induced by electrical stimulation of the dorsal periaqueductal gray.
Broiz AC; Bassi GS; De Souza Silva MA; Brandão ML
Neuroscience; 2012 Jan; 201():134-45. PubMed ID: 22123168
[TBL] [Abstract][Full Text] [Related]
55. Role of TRPV1 channels of the dorsal periaqueductal gray in the modulation of nociception and open elevated plus maze-induced antinociception in mice.
Mascarenhas DC; Gomes KS; Nunes-de-Souza RL
Behav Brain Res; 2015 Oct; 292():547-54. PubMed ID: 26183651
[TBL] [Abstract][Full Text] [Related]
56. Stereoselectivity of the anxiolytic effect of propranolol microinjected into the dorsal midbrain central gray.
Audi EA; de-Oliveira RM; de-Oliveira CE; Graeff FG
Braz J Med Biol Res; 1990; 23(10):985-7. PubMed ID: 2101065
[TBL] [Abstract][Full Text] [Related]
57. Reversal of benzodiazepine inverse agonist FG 7142-induced anxiety syndrome by neurosteroids in mice.
Reddy DS; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):665-81. PubMed ID: 9542718
[TBL] [Abstract][Full Text] [Related]
58. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
Mendes-Gomes J; Nunes-de-Souza RL
Brain Res; 2005 Jun; 1047(1):97-104. PubMed ID: 15893297
[TBL] [Abstract][Full Text] [Related]
59. Evidence for mediation of nociception by injection of the NK-3 receptor agonist, senktide, into the dorsal periaqueductal gray of rats.
Bassi GS; Broiz AC; Gomes MZ; Brandão ML
Psychopharmacology (Berl); 2009 May; 204(1):13-24. PubMed ID: 19093101
[TBL] [Abstract][Full Text] [Related]
60. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR
Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
